Gene Amplification in Rhabdomyosarcoma: Lessons from a Rare Cancer.
WHY IT MATTERS
This research identifies specific genetic changes in rhabdomyosarcoma that could lead to targeted treatments tailored to each patient's tumor genetics, potentially improving survival rates for children with this aggressive cancer.
Scientists studying a rare childhood cancer called alveolar rhabdomyosarcoma have discovered how cancer cells make extra copies of certain genes that help them grow. They found that different parts of chromosomes (the structures that hold our genes) get copied in different ways—some amplify just one gene, while others amplify multiple genes at once. Understanding these patterns helps doctors figure out which patients might need different treatments.
Gene Amplification in Rhabdomyosarcoma: Lessons from a Rare Cancer. Abstract: Studies of the pediatric soft tissue cancer alveolar rhabdomyosarcoma have contributed to the current understanding of the diverse set of molecular changes that occur as part of the gene amplification process. In accord with the traditional view of amplification, the amplicon from the 2p24 chromosomal region primarily involves a single protein-coding gene ( MYCN ). In contrast, amplification of the 12q13-q14 chromosomal region involves a gene-rich region in which there are at least two critical protein-coding oncogenic targets ( CDK4 and SHMT2 ). Amplicons involving the 1p36 and 13q14 chromosomal regions co-occur as part of a multistep process in which a mutation, in this case a translocation that forms a gene fusion ( PAX7::FOXO1 ), is followed by amplification. Analysis of the amplicon i Authors: Barr Journal: International journal of molecular sciences MeSH: Humans, Gene Amplification, Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Cyclin-Dependent Kinase 4, Rare Diseases
ASK YOUR DOCTOR
If your child has been diagnosed with alveolar rhabdomyosarcoma, ask your oncologist whether genetic testing of the tumor for MYCN, CDK4, or PAX7::FOXO1 changes has been done, as this may guide treatment options.